EDWARDS LIFESCIENCES CORP (EW) Stock Price, Quote, News and Overview
NYSE:EW - New York Stock Exchange, Inc. - US28176E1082 - Common Stock - Currency: USD
EW Quote, Performance and Key Statistics
76.04
+0.91 (+1.21%)
The current stock price of EW is 76.04 USD. In the past month the price increased by 6.81%. In the past year, price decreased by -12.02%.
EW Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
| SYK | STRYKER CORP | 29.95 | 139.34B | ||
| MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
| IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
| RMD | RESMED INC | 25.98 | 34.64B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
| DXCM | DEXCOM INC | 43.43 | 28.10B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B | ||
| STE | STERIS PLC | 24.51 | 22.11B |
Related stock screener links
About EW
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Company Info
EDWARDS LIFESCIENCES CORP
One Edwards Way
Irvine CALIFORNIA 92614 US
CEO: Michael A. Mussallem
Employees: 19800
Company Website: https://www.edwards.com
Investor Relations: https://ir.edwards.com/
Phone: 19492502500
EDWARDS LIFESCIENCES CORP / EW FAQ
What is the stock price of EDWARDS LIFESCIENCES CORP today?
The current stock price of EW is 76.04 USD. The price increased by 1.21% in the last trading session.
What is the ticker symbol for EDWARDS LIFESCIENCES CORP stock?
The exchange symbol of EDWARDS LIFESCIENCES CORP is EW and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is EW stock listed?
EW stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for EDWARDS LIFESCIENCES CORP stock?
41 analysts have analysed EW and the average price target is 81.09 USD. This implies a price increase of 6.64% is expected in the next year compared to the current price of 76.04. Check the EDWARDS LIFESCIENCES CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EDWARDS LIFESCIENCES CORP worth?
EDWARDS LIFESCIENCES CORP (EW) has a market capitalization of 44.70B USD. This makes EW a Large Cap stock.
How many employees does EDWARDS LIFESCIENCES CORP have?
EDWARDS LIFESCIENCES CORP (EW) currently has 19800 employees.
What are the support and resistance levels for EDWARDS LIFESCIENCES CORP (EW) stock?
EDWARDS LIFESCIENCES CORP (EW) has a support level at 75.92 and a resistance level at 76.19. Check the full technical report for a detailed analysis of EW support and resistance levels.
Is EDWARDS LIFESCIENCES CORP (EW) expected to grow?
The Revenue of EDWARDS LIFESCIENCES CORP (EW) is expected to grow by 0.76% in the next year. Check the estimates tab for more information on the EW EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EDWARDS LIFESCIENCES CORP (EW) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EW, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EW, evaluating the profitability, health, valuation and growth aspects
- EDWARDS LIFESCIENCES CORP (EW) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EDWARDS LIFESCIENCES CORP (EW) Sales and EPS estimates to see what analysts future expectations are.
- EDWARDS LIFESCIENCES CORP (EW) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EDWARDS LIFESCIENCES CORP (EW) Insider and Institutional Ownership to learn about the owners and their transactions.
- EDWARDS LIFESCIENCES CORP (EW) Stock Chart to make your own analysis
- EDWARDS LIFESCIENCES CORP (EW) Latest news and press-releases to stay up to date.
Does EDWARDS LIFESCIENCES CORP (EW) stock pay dividends?
EW does not pay a dividend.
When does EDWARDS LIFESCIENCES CORP (EW) report earnings?
EDWARDS LIFESCIENCES CORP (EW) will report earnings on 2025-07-22, after the market close.
What is the Price/Earnings (PE) ratio of EDWARDS LIFESCIENCES CORP (EW)?
The PE ratio for EDWARDS LIFESCIENCES CORP (EW) is 29.25. This is based on the reported non-GAAP earnings per share of 2.6 and the current share price of 76.04 USD. Check the full fundamental report for a full analysis of the valuation metrics for EW.
What is the Short Interest ratio of EDWARDS LIFESCIENCES CORP (EW) stock?
The outstanding short interest for EDWARDS LIFESCIENCES CORP (EW) is 1.64% of its float. Check the ownership tab for more information on the EW short interest.
EW Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to EW. When comparing the yearly performance of all stocks, EW turns out to be only a medium performer in the overall market: it outperformed 56.88% of all stocks.
EW Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to EW. EW gets an excellent profitability rating and is at the same time showing great financial health properties.
EW Financial Highlights
Over the last trailing twelve months EW reported a non-GAAP Earnings per Share(EPS) of 2.6. The EPS increased by 1.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 76.28% | ||
| ROA | 31.98% | ||
| ROE | 41.75% | ||
| Debt/Equity | 0.06 |
EW Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to EW. The Buy consensus is the average rating of analysts ratings from 41 analysts.
For the next year, analysts expect an EPS growth of -3.21% and a revenue growth 0.76% for EW